Does RISANKIZUMAB-RZAA Cause Deafness unilateral? 50 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Deafness unilateral have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
50
Reports of Deafness unilateral with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
5
Hospitalizations
How Dangerous Is Deafness unilateral From RISANKIZUMAB-RZAA?
Of the 50 reports, 5 (10.0%) required hospitalization.
Is Deafness unilateral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Deafness unilateral?
ADALIMUMAB (351)
TADALAFIL (99)
DIMETHYL (77)
RITUXIMAB (70)
ETANERCEPT (60)
IBRUTINIB (57)
METHOTREXATE (57)
INTERFERON BETA-1A (55)
SECUKINUMAB (52)
APIXABAN (49)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Deafness unilateral Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA